Serina Therapeutics Stock
Serina Therapeutics, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Steven A. Ledger
- Employees
- 16
- Market cap
- $26 M
- IPO
- 28/11/2018
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214,…
Serina Therapeutics stock: price history
1D
-3.9%
1W
-14.0%
1M
-20.4%
6M
-16.1%
YTD
-9.9%
1Y
-64.8%
2Y
-77.2%
5Y
-94.8%
10Y
–
Next earnings date
Next earnings date
18/11/2026 (in 32 days)
Volatility around earnings
~46% stronger price swings than usual
Ask the agents about Serina Therapeutics
Analyst assessment of Serina Therapeutics
0
STRONG BUY
2
BUY
0
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Buy
As of: 10/09/2026
Serina Therapeutics stock metrics
P/E
-0.91
P/B
1.5
EV/EBITDA
-0.27
RETURN ON EQUITY
-33.9%
NET MARGIN
0.0%
DEBT/EQUITY
0.17
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
13.3%
FLOAT SHARES
1,992,132
AVG. DAILY VOLUME (30D)
82,549
Insider transactions (SEC)
Brannan Stephen K.
Bailey Gregory
Bailey Gregory
Venkatesan Jay
Venkatesan Jay
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Serina Therapeutics stock
What does Serina Therapeutics do?
Serina Therapeutics, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Steven A. Ledger, the company employs around 16 people.
The IPO was on 28/11/2018; the stock trades on AMEX under the ticker SER.
What do analysts say about Serina Therapeutics stock?
2 analysts rate the stock, the consensus is Buy (as of 10/09/2026).
This is an external assessment, not a statement by Market Jury.
When does Serina Therapeutics report next?
The next earnings date is 18/11/2026.
Around past earnings, price swings were roughly 46% stronger than usual.
Does Serina Therapeutics pay a dividend?
No, Serina Therapeutics currently does not pay a dividend.
Which stocks are comparable to Serina Therapeutics?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Serina Therapeutics stock analyzed?
Clicking "Analyze stock" lets five strategies assess Serina Therapeutics against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.